Correction: Research progress of B7-H3 in malignant tumors

Saved in:
Bibliographic Details
Main Authors: Shuaixiang Zhao, He Zhang, Guanning Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1641733/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334103472603136
author Shuaixiang Zhao
Shuaixiang Zhao
He Zhang
Guanning Shang
Guanning Shang
author_facet Shuaixiang Zhao
Shuaixiang Zhao
He Zhang
Guanning Shang
Guanning Shang
author_sort Shuaixiang Zhao
collection DOAJ
format Article
id doaj-art-69e72d831334414abd5f93dc3cf95eaa
institution Kabale University
issn 1664-3224
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-69e72d831334414abd5f93dc3cf95eaa2025-08-20T03:45:40ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.16417331641733Correction: Research progress of B7-H3 in malignant tumorsShuaixiang Zhao0Shuaixiang Zhao1He Zhang2Guanning Shang3Guanning Shang4Department of Bone and Soft Tissue Oncology, Department of Orthopaedic, Shengjing Hospital, China Medical University, Shenyang, Liaoning, ChinaThe First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, ChinaDepartment of Bone and Soft Tissue Oncology, Department of Orthopaedic, Shengjing Hospital, China Medical University, Shenyang, Liaoning, ChinaDepartment of Bone and Soft Tissue Oncology, Department of Orthopaedic, Shengjing Hospital, China Medical University, Shenyang, Liaoning, ChinaThe First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1641733/fullB7-H3(CD276)malignant tumortargeted therapyimmunitydrug trials
spellingShingle Shuaixiang Zhao
Shuaixiang Zhao
He Zhang
Guanning Shang
Guanning Shang
Correction: Research progress of B7-H3 in malignant tumors
Frontiers in Immunology
B7-H3(CD276)
malignant tumor
targeted therapy
immunity
drug trials
title Correction: Research progress of B7-H3 in malignant tumors
title_full Correction: Research progress of B7-H3 in malignant tumors
title_fullStr Correction: Research progress of B7-H3 in malignant tumors
title_full_unstemmed Correction: Research progress of B7-H3 in malignant tumors
title_short Correction: Research progress of B7-H3 in malignant tumors
title_sort correction research progress of b7 h3 in malignant tumors
topic B7-H3(CD276)
malignant tumor
targeted therapy
immunity
drug trials
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1641733/full
work_keys_str_mv AT shuaixiangzhao correctionresearchprogressofb7h3inmalignanttumors
AT shuaixiangzhao correctionresearchprogressofb7h3inmalignanttumors
AT hezhang correctionresearchprogressofb7h3inmalignanttumors
AT guanningshang correctionresearchprogressofb7h3inmalignanttumors
AT guanningshang correctionresearchprogressofb7h3inmalignanttumors